IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CATTANEO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.201
AS - Asia 3.162
EU - Europa 2.801
SA - Sud America 621
Continente sconosciuto - Info sul continente non disponibili 77
AF - Africa 68
OC - Oceania 7
Totale 12.937
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.039
CN - Cina 1.280
SG - Singapore 997
UA - Ucraina 774
DE - Germania 531
BR - Brasile 506
IT - Italia 479
HK - Hong Kong 322
FR - Francia 236
FI - Finlandia 186
VN - Vietnam 179
GB - Regno Unito 166
RU - Federazione Russa 151
TR - Turchia 120
IE - Irlanda 110
CA - Canada 82
IN - India 72
BD - Bangladesh 66
AR - Argentina 42
ZA - Sudafrica 32
MX - Messico 30
SE - Svezia 28
PL - Polonia 25
EC - Ecuador 24
IQ - Iraq 22
NL - Olanda 20
BE - Belgio 18
JP - Giappone 18
ES - Italia 17
CO - Colombia 16
ID - Indonesia 13
PK - Pakistan 13
LT - Lituania 11
AT - Austria 10
EU - Europa 10
TT - Trinidad e Tobago 10
VE - Venezuela 10
JM - Giamaica 8
PY - Paraguay 8
UZ - Uzbekistan 8
CL - Cile 7
CR - Costa Rica 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
DZ - Algeria 6
EE - Estonia 6
NG - Nigeria 6
AZ - Azerbaigian 5
IL - Israele 5
KE - Kenya 5
MA - Marocco 5
PA - Panama 5
SA - Arabia Saudita 5
UY - Uruguay 5
AL - Albania 4
PH - Filippine 4
RS - Serbia 4
TN - Tunisia 4
EG - Egitto 3
GT - Guatemala 3
IR - Iran 3
LB - Libano 3
MK - Macedonia 3
MU - Mauritius 3
NI - Nicaragua 3
PR - Porto Rico 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NP - Nepal 2
RO - Romania 2
SV - El Salvador 2
TH - Thailandia 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
GI - Gibilterra 1
HR - Croazia 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
Totale 12.859
Salva come PNG Salva come JPEG
Città #
Ashburn 547
Jacksonville 536
Singapore 493
Fairfield 447
Woodbridge 422
San Jose 357
Hong Kong 322
Houston 309
Beijing 277
Ann Arbor 239
The Dalles 222
Princeton 213
Cambridge 209
Nanjing 198
Wilmington 198
Council Bluffs 182
Seattle 173
Chandler 143
New York 128
Columbus 117
Dublin 110
Los Angeles 103
Istanbul 97
Lauterbourg 92
Helsinki 79
Milan 74
Nanchang 70
São Paulo 65
Ho Chi Minh City 63
Moscow 59
Des Moines 57
Hebei 57
Dallas 56
Buffalo 54
Changsha 45
Shenyang 45
Hanoi 42
San Diego 36
Kunming 34
Shanghai 33
San Francisco 32
Tianjin 32
Jiaxing 31
Lancaster 31
Santa Clara 31
Chicago 28
Jinan 28
Munich 28
Toronto 28
Rome 24
Atlanta 21
Brooklyn 21
Orem 21
Redondo Beach 21
Charlotte 19
Brussels 17
Hangzhou 17
Johannesburg 16
London 16
Mexico City 16
Rio de Janeiro 16
Tokyo 16
Nürnberg 15
Verona 15
Warsaw 15
Zhengzhou 15
Montreal 14
Phoenix 14
Brescia 13
Haikou 12
San Mateo 12
Augusta 11
Chennai 11
Guayaquil 11
Lanzhou 11
Miami 11
Belo Horizonte 10
Dearborn 10
Dhaka 10
Frankfurt am Main 10
Kocaeli 10
Monmouth Junction 10
Ningbo 10
North Bergen 10
Curitiba 9
Guangzhou 9
North Charleston 9
Taiyuan 9
Trieste 9
Boston 8
Da Nang 8
Denver 8
Taizhou 8
Turku 8
Vienna 8
Amsterdam 7
Baghdad 7
Brasília 7
Fuzhou 7
Genoa 7
Totale 7.901
Salva come PNG Salva come JPEG
Nome #
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 230
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 214
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 201
Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. 186
Desensibilizzazione orale alla rifampicina: descrizione di un nuovo protocollo. 174
Expression of CD28 on CD8+ and CD4+ Lymphocytes During HIV Infection 172
CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. 169
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 166
Studio con TC ad alta risoluzione (HRCT) dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 163
In vitro cell death of activated lymphocytes in Omenn's syndrome 162
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 156
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 154
Antiphospholipid antibody: laboratory, pathogenesis and clinical manifestations 153
Discordance for systemic lupus erythematosus and hyper IgE syndrome in a pair of monozygotic twins 151
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 147
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 147
Circulating immune complexes in human acute leukaemia. 143
Esposizione a latice nelle aziende sanitarie: esperienze pratiche 142
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 141
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. 139
Deforming arthropathy of the hands in Systemic Lupus Erythematosus is associated with antibodies to SS-A/Ro and to SS-B/La. 138
Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases. 137
Prevenzione delle reazioni allergiche in pazienti sensibilizzati a latice 136
Upregulation of myxovirus-resistance protein A: a possible marker of type I interferon induction in systemic sclerosis. 136
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 136
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA E LUPUS ERITEMATOSO SISTEMICO: DIFFERENZE E SOMIGLIANZE GENETIHE 136
The anti-beta-2 glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. 135
Anti beta2-glycoprotein I antibodies: clinical significance. 135
Treatment with etanercept in six patients with chronic hepatitis C infection and systemic autoimmune diseases. 134
Oesophageal manometry in early and definite systemic sclerosis. 131
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 131
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA: FOCUS SULLE MANIFESTAZIONI NEUROLOGICHE 130
Antinuclear antibodies in psoriatic arthritis and its subgroups 129
Antiperinuclear factor in psoriatic arthropathy 128
Anti-Ku antibodies in connective tissue disease: clinical and serologic evaluation of 14 patients. 128
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases: a multicentre prospective study. 128
Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients 128
Anticorpi antinucleo e artrite psoriasica 127
Nonorgan specific autoantibodies and heart damage. 127
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 126
The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis 125
Anti-TNF-alpha treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients 124
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations. 123
Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. 123
Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block. 123
EVALUATION OF NEUROLOGICAL MANIFESTATIONS IN 180 PATIENTS (PTS) WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME (PAPS) 123
Defective expression of HLA class I and CD1a molecules in boy with Marfan-like phenotype and deep skin ulcers 122
Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell-death 121
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 121
Vasculite orticarioide: valutazione clinica, laboratoristica e terapeutica di 17 pazienti. 121
Antiphospholipid antibodies and malignancies 121
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 120
RELATIONSHIP BETWEEN SLE SUSCEPTIBILITY GENES AND CLINICAL MANIFESTATIONS IN A COHORT OF PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME 120
Pregnancy in systemic sclerosis: a prospective study 119
Systemic lupus erythematosus and pregnancy: a prospective study. 118
Anti-Ro/SSA antibodies in rheumatoid arthritis: clinical and immunologic associations. 118
Role of anti-prothrombin in antiphospholipid syndrome. 118
Clinical and serological features of 35 patients with anti-Ki autoantibodies. 116
More on anticardiolipin and anti-beta2 glycoprotein I in systemic sclerosis. 116
MANIFESTAZIONI NEUROLOGICHE IN 180 PAZIENTI CON SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA. RUOLO DEI FATTORI DI RISCHIO CARDIOVASCOLARI 115
Chilblain Lupus Erythematosus (CL) è associato ad anticorpi anti SSA/Ro 114
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of Low-dose versus high-dose intravenous cyclophosphamide. 113
Antinuclear antibodies and psoriatic arthritis 112
NEUROLOGICAL MANIFESTATIONS IN 169 PATIENTS WITH PAPS: WHICH SIGNIFICANCE FOR SMALL HYPERINTENSE WHITE MATTER LESIONS AT MAGNETIC RESONANCE IMAGING? 112
IL "PROFILO" DEGLI ANTICORPI ANTIFOSFOLIPIDI NELLA SINDROME PRIMARIA COME FATTORE DI RISCHIO PER EVENTI CLINICI: STUDIO DI 175 PAZIENTI 111
Proliferazioni di cloni di tipo Th2 con fenotipo CD3- CD4+. Studio di 2 casi. 110
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients. 110
Anti-TNFalpha treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies. 109
Undifferentiated connective tissue disease with antibodies to Ro/SSA: clinical features and follow-up of 148 patients 109
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 108
[A high-resolution computed tomographic study of the pulmonary interstitium in systemic autoimmune diseases] Studio con tomografia computerizzata con alta risoluzione dell’interstizio polmonare in alcune malattie autoimmunitarie sistemiche. 107
Esophageal Dysfunction in Patients with Definite and Early Systemic Sclerosis 107
ANTICORPI ANTIFOSFOLIPIDI E NEOPLASIE (aPL E NEOPLASIE) 107
Lymphadenopathic and oropharyngeal Kaposi's sarcoma in a drug addict with acquired immunodeficiency syndrome. Immunological abnormalities in peripheral blood and lymphoid tissue 107
Decreased number of peripheral blood CD4 + CD29+ lymphocytes and increased in vitro spontaneous production of anti-DNA antibodies in patients with active systemic lupus erythematosus. 106
PREGNANCY OUTCOMES IN WOMEN EXPOSED TO BIOLOGIC TREATMENT AND AFFECTED BY CHRONIC ARTHRITIS 105
IL METHOTREXATE (MTX) E I GENOTIPI DELLA METILENTETRAIDROFOLATOREDUTTASI (MTHFR) NEL TRATTAMENTO DI PAZIENTI ITALIANI CON MALATTIE REUMATICHE 103
Isotype switching and titer variation of anti-Ro/SSA antibodies over time in 100 patients with undifferentiated connective tissue disease (UCTD). 103
Esofagopatia sclerodermia in pazienti con sclerosi sistemica (SSC) “precoce” secondo Le Roy-Mesdger: confronto con altri subset di malattia. Studio clinico-manometrico di 181 pazienti 102
Chillblain lupus erythematosus is associated with antibodies to SSA/Ro 100
CONNETTIVITE INDIFFERENZIATA (UCTD) DI RECENTE DIAGNOSI: PROFILO CLINICO ED IMMUNOLOGICO 100
The neonatal lupus erythematosus associated with isolated LA(SSB) antibodies. 100
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 99
Antiperinuclear factor (APF) in patients with psoriasic arthtritis 98
Oesophageal dysfunction in patients with definite and early systemic sclerosis 96
TERAPIE BIOLOGICHE E GRAVIDANZA: RISULTATI DI UNO STUDIO MULTICENTRICO ITALIANO 94
Chronic urticaria induced by eradication therapy of Helicobacter pilori: a case report. 93
L'orticaria. 93
Anti-TNFalpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients 92
Lessons from the "Euro-Lupus Cohort". 92
Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. 92
Discordance for Systemic LupusErythematosus and Hyper IgE Syndrome in a pair of monozygous twins 91
Chilblain Lupus Erythematosus (CL) is associated with antibodies SSA/Ro 91
European Working Party on Systemic Lupus Erythematosus. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". 90
European Working Party on Systemic Lupus Erythematosus. Lessons from the "Euro-Lupus Cohort". 90
Pretransplant antitumor conditioning (fTBI dose) correlates with bone marrow histology at day 0 in leukemic patients. 87
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 87
Antiphospholipid antibodies and intestinal pathology 86
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 84
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases 82
Totale 12.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022568 0 0 0 56 12 27 22 56 39 87 70 199
2022/2023576 113 5 5 20 58 173 3 54 96 3 16 30
2023/2024630 53 19 41 31 13 102 21 23 216 3 1 107
2024/20251.500 2 7 5 177 218 116 99 52 149 127 362 186
2025/20263.188 345 503 245 515 305 192 421 125 162 245 88 42
2026/20271.110 196 167 321 426 0 0 0 0 0 0 0 0
Totale 12.937